Research shows that black African American adults in the US are 77% more luckily to be diagnosed with type 2 diabetes than non-Hispanic white adults.  However, ethnic minorities that include African Americans are significantly underrepresented in critical trials.  Although pharmaceutical companies are aware of this, only recently have they become more active. Last week, Boehringer [...]